Community access to pneumonia (CAP) is a case of pneumonia contracted outside the hospital, including pneumonia, which occurs during the average incubation period after admission with a pathogen infection with a specific incubation period. Antibiotic treatment is one of the main means of treatment, as detailed below:
(a) Initial empirical treatment For young, non-basic patients with a lighter condition (CURB-65 score 0-1), the common pathogens are pneumococococcal, pneumopathogen, chlamydia, etc. For basic diseases (e.g. chronic obstructive pulmonary disease, diabetes, cardiovascular disease, etc.) or old-age patients (age 65), CURB-65 score ≥2, which is more serious. In addition to the above-mentioned pathogens, the common pathogens include haemophilus influenzae, golden grapes, gland cactus, etc. Antibiotic choice For patients with a milder condition, the first choice is fluorine phenolone, large cycline-based antibiotics, such as moxia, achiccin or caracinin. This drug has good antibacterial activity in the pneumococcal terracis, chlamydia and some pneumocococcus. For example, Achicillin has a wider antibacterial spectrum, high concentrations in tissues, and has long postbiotic effects, which are easy to take, usually by oral delivery, once a day, with a general treatment of 5-7 days. But our country has a high resistance rate to parageny pneumonia for Achicillin, which is not recommended for use alone with β-nimamine antibiotics.
When the pathogen is identified through a microbiological examination (e.g., haemorrhagic culture, etc.), a precise antibiotic treatment programme should be provided based on the results of the drug sensitivity. In the case of pneumococcus infection, which is sensitive to penicillin, it is treated with penicillin G alone; in the case of penicillin-resistant pneumocococcus, it is optional to use antibiotics such as head spines and left oxyfluzone. The use of anti-influenza virus drugs, such as Ostawe, within 48 hours, can be effective in reducing symptoms and reducing the rate of disease. If bacterial infections are combined, there is a need for joint use of antibiotics on the basis of antiretroviral treatment. For amphibious pneumocococcal pneumonia, the primary choice is the Great ethylene-type antibiotics (e.g., Achicillin) or the hydrophenone-type antibiotics (e.g., left-oxen fluoride). Armour fungi is an aerobic glycol fungi, which is easily grown in such environments as air-conditioning systems, hot water pipes and, when infected, can cause high heat, cough, respiratory difficulties, which can effectively inhibit the growth and reproduction of the legionella.
The general course of treatment is 7 – 10 days for the general community to receive pneumonia. In the case of atypical pathogen infections such as chlamydia and chlamydia, the treatment process may be longer, typically 10 – 14 days. In the course of treatment, the treatment is judged on the patient ‘ s symptoms, signs and laboratory results. If fever does not improve within 72 hours of admission, the possibility of failure is considered. When the patient’s body temperature is normal for 3-5 days, the symptoms of cough, cough, etc. are significantly reduced, and the haemorrhagic pattern, C-reacting inflammation indicators, etc., are back to normal, a stoppage may be considered. Special circumstances For patients with low immune functions (e.g. AIDS patients, those with long-term use of sugar-coated hormones or immunosuppressants), care is taken to identify and diagnose the potential of specific pathogens to resist infections, such as pneumocococcal pneumonia, fungi, etc. The treatment process may require an appropriate extension to ensure that the pathogen is completely removed and that the recurrence is prevented.
pneumonia
